Opioid prescribing exceeds consumption following common surgical oncology procedures
| Autor: | Jay S. Lee, Chad M. Brummett, Michael J. Englesbe, Jennifer F. Waljee, Michael S. Sabel, Lesly A. Dossett, Nicholas W. Eyrich, Ryan Howard, Kenneth R. Sloss, Michael P Klueh |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Breast biopsy
medicine.medical_specialty medicine.medical_treatment Breast Neoplasms Drug Prescriptions Article 03 medical and health sciences 0302 clinical medicine Surgical oncology Surveys and Questionnaires medicine Humans Prospective Studies Practice Patterns Physicians' Medical prescription Mastectomy Pain Postoperative medicine.diagnostic_test business.industry Wide local excision Lumpectomy General Medicine Prognosis Analgesics Opioid Surgical Oncology Oncology Opioid 030220 oncology & carcinogenesis Emergency medicine Female 030211 gastroenterology & hepatology Surgery business Oxycodone Follow-Up Studies medicine.drug |
| Zdroj: | J Surg Oncol |
| ISSN: | 1096-9098 0022-4790 |
| Popis: | BACKGROUND AND OBJECTIVES Surgical oncology patients are vulnerable to persistent opioid use. As such, we aim to compare opioid prescribing to opioid consumption for common surgical oncology procedures. METHODS We prospectively identified patients undergoing common surgical oncology procedures at a single academic institution (August 2017-March 2018). Patients were contacted by telephone within 6 months of surgery and asked to report their opioid consumption and describe their discharge instructions and opioid handling practices. RESULTS Of the 439 patients who were approached via telephone, 270 completed at least one survey portion. The median quantity of opioid prescribed was significantly larger than consumed following breast biopsy (5 vs. 2 tablets of 5 mg oxycodone, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text